ABSTRACT-The antibody 3F8, an IgG3 murine monoclonal anti-body (MoAb) against disialoganglioside G02, could target iodine-131 (131 1) to established subcutaneous human neuroblastoma (NB) xenografts in BALB/c nude mice. 1311-radiolabeled MoAb (0.125-1 mCi) was injected iv. Tumor radioactivity over time was calculated from scintigraphy, and radiation dose to individual tumors was cal-culated. Tumor shrinkage occurred only with 131 I-labeled 3F8, but not with nonradioactive 3F8 or radiolabeled irrelevant antibody. While the tumor of the control mice enlarged by tenfold, the treated tumor showed over 95 % shrinkage by 12 days. Both the rate of shrinkage and duration of tumor response were dose dependent. Calculated doses of more than 10,000 rad...
BACKGROUND: A new promising approach to improve the outcome of head and neck squamous cell carcinoma...
Radioimmunotherapy (RIT) has been shown to be a practicable way to treat head and neck squamous cell...
Purpose: To assess the efficacy of different schedules for combining external beam radiotherapy (EBR...
We developed an animal model to evaluate the 125-I-metaiodobenzylguanidine (125-I-mIBG) biodistr...
We report the radioimmunotherapy of mouse B-cell lym-phoma, BCL1, using a panel of anti–B-cell monoc...
3F8 is a murine IgG3 monoclonal antibody (MAb) selective for the ganglioside G(D2). Previous studies...
<p>a) changes in tumor volume; b) control untreated mouse; c) mouse treated with 600 µCi <sup>188</s...
Advances in the treatment of patients with cancer, have come from the use of relatively toxic agents...
The purpose of our study was to determine the effect of tumor-targeted radiation in neuroblastoma by...
A mixture of 3 MAbs directed against 3 different CEA epitopes was radiolabelled with 131I and used f...
Biodistribution and imaging characteristics of monoclonal antibody B3 were evaluated in nude mice be...
During one week, beginning 18 days after transplantation, nude mice bearing human colon carcinoma ra...
Radioimmunotherapy using radiolabeled monoclonal antibodies (MoAbs) directed against tumor-associate...
Radioimmunotherapy (RIT) with i.v. administered radiolabeled IgG can selectively irradiate tumor cel...
The recent development of hybridoma technology, providing monoclonal antibodies (MoAb) of predefined...
BACKGROUND: A new promising approach to improve the outcome of head and neck squamous cell carcinoma...
Radioimmunotherapy (RIT) has been shown to be a practicable way to treat head and neck squamous cell...
Purpose: To assess the efficacy of different schedules for combining external beam radiotherapy (EBR...
We developed an animal model to evaluate the 125-I-metaiodobenzylguanidine (125-I-mIBG) biodistr...
We report the radioimmunotherapy of mouse B-cell lym-phoma, BCL1, using a panel of anti–B-cell monoc...
3F8 is a murine IgG3 monoclonal antibody (MAb) selective for the ganglioside G(D2). Previous studies...
<p>a) changes in tumor volume; b) control untreated mouse; c) mouse treated with 600 µCi <sup>188</s...
Advances in the treatment of patients with cancer, have come from the use of relatively toxic agents...
The purpose of our study was to determine the effect of tumor-targeted radiation in neuroblastoma by...
A mixture of 3 MAbs directed against 3 different CEA epitopes was radiolabelled with 131I and used f...
Biodistribution and imaging characteristics of monoclonal antibody B3 were evaluated in nude mice be...
During one week, beginning 18 days after transplantation, nude mice bearing human colon carcinoma ra...
Radioimmunotherapy using radiolabeled monoclonal antibodies (MoAbs) directed against tumor-associate...
Radioimmunotherapy (RIT) with i.v. administered radiolabeled IgG can selectively irradiate tumor cel...
The recent development of hybridoma technology, providing monoclonal antibodies (MoAb) of predefined...
BACKGROUND: A new promising approach to improve the outcome of head and neck squamous cell carcinoma...
Radioimmunotherapy (RIT) has been shown to be a practicable way to treat head and neck squamous cell...
Purpose: To assess the efficacy of different schedules for combining external beam radiotherapy (EBR...